EVOLEX, created in 1998 (Switzerland), from 2951 sister brands and 17477 competing brands. The EVOLEX brand is owned by NOVARTIS N, a company listed in Zurich. The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. EVOLEX belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(EVOLEX)
over 5 years*
CHF 99.86